Annual Drug Patent Expirations for INTUNIV
Intuniv is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for INTUNIV.
The generic ingredient in INTUNIV is guanfacine hydrochloride. One supplier is listed for this compound. Additional details are available on the guanfacine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
